CKPT Stock Price: Over 30% Increase Pre-Market Explanation

By Amit Chowdhry ● June 9, 2021
  • The stock price of Checkpoint Therapeutics Inc (NASDAQ: CKPT) increased by over 30% pre-market. This is why it happened.

The stock price of Checkpoint Therapeutics Inc (NASDAQ: CKPT) increased by over 30% pre-market. Investors are responding positively to a bullish research report. 

B. Riley analyst Justin Walsh initiated coverage of the company shares with a “Buy” rating. And Walsh assigned the company an $18 price target. The $18 price target imputes about a 577% upside to the current stock price.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.